Uni-Bio Science Group Limited (0690.HK)
HKD 0.08
(2.67%)
HKD 0.08
(2.67%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 52.86 Million HKD | 133.18% |
| 2022 | 22.67 Million HKD | 305.0% |
| 2021 | 5.59 Million HKD | 78.39% |
| 2020 | 3.13 Million HKD | 180.93% |
| 2019 | 1.11 Million HKD | -91.69% |
| 2018 | 13.44 Million HKD | 0.0% |
| 2017 | - HKD | -100.0% |
| 2016 | 10.99 Million HKD | 13.74% |
| 2015 | 9.66 Million HKD | -44.78% |
| 2014 | 17.49 Million HKD | 0.0% |
| 2013 | - HKD | -100.0% |
| 2012 | 129.81 Million HKD | 48.75% |
| 2011 | 87.27 Million HKD | 244.79% |
| 2010 | 25.31 Million HKD | -21.09% |
| 2009 | 32.07 Million HKD | 26.57% |
| 2008 | 25.34 Million HKD | 153.41% |
| 2007 | 10 Million HKD | -90.97% |
| 2006 | 110.78 Million HKD | 84.62% |
| 2005 | 60 Million HKD | 25.47% |
| 2004 | 47.82 Million HKD | 10.52% |
| 2003 | 43.27 Million HKD | -46.16% |
| 2002 | 80.37 Million HKD | 169.3% |
| 2001 | 29.84 Million HKD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 82.79 Million HKD | 11.11% |
| 2024 Q1 | 82.79 Million HKD | 56.61% |
| 2023 Q1 | 17.13 Million HKD | -24.42% |
| 2023 Q3 | 52.39 Million HKD | 159.55% |
| 2023 Q2 | 20.18 Million HKD | 17.81% |
| 2023 Q4 | 52.86 Million HKD | 0.91% |
| 2023 FY | 52.86 Million HKD | 133.18% |
| 2022 Q1 | 5.24 Million HKD | -6.4% |
| 2022 Q3 | 18.79 Million HKD | 132.47% |
| 2022 FY | 22.67 Million HKD | 305.0% |
| 2022 Q4 | 22.67 Million HKD | 20.63% |
| 2022 Q2 | 8.08 Million HKD | 54.29% |
| 2021 Q4 | 5.59 Million HKD | 468.32% |
| 2021 FY | 5.59 Million HKD | 78.39% |
| 2021 Q1 | 3.28 Million HKD | 4.65% |
| 2021 Q2 | 7.66 Million HKD | 133.4% |
| 2021 Q3 | 985 Thousand HKD | -87.15% |
| 2020 Q1 | - HKD | -100.0% |
| 2020 FY | 3.13 Million HKD | 180.93% |
| 2020 Q2 | 187 Thousand HKD | 0.0% |
| 2020 Q3 | 2.1 Million HKD | 1026.74% |
| 2020 Q4 | 3.13 Million HKD | 48.93% |
| 2019 FY | 1.11 Million HKD | -91.69% |
| 2019 Q1 | 13.73 Million HKD | 2.13% |
| 2019 Q2 | 15.39 Million HKD | 12.12% |
| 2019 Q3 | - HKD | -100.0% |
| 2019 Q4 | 1.11 Million HKD | 0.0% |
| 2018 Q2 | - HKD | 0.0% |
| 2018 FY | 13.44 Million HKD | 0.0% |
| 2018 Q3 | 13.44 Million HKD | 0.0% |
| 2018 Q4 | 13.44 Million HKD | 0.0% |
| 2018 Q1 | - HKD | 0.0% |
| 2017 Q4 | - HKD | 0.0% |
| 2017 FY | - HKD | -100.0% |
| 2017 Q3 | - HKD | 0.0% |
| 2017 Q2 | - HKD | 0.0% |
| 2017 Q1 | - HKD | -100.0% |
| 2016 FY | 10.99 Million HKD | 13.74% |
| 2016 Q4 | 10.99 Million HKD | 0.0% |
| 2016 Q3 | 10.99 Million HKD | -4.52% |
| 2016 Q2 | 11.51 Million HKD | 0.0% |
| 2016 Q1 | 11.51 Million HKD | 19.13% |
| 2015 Q4 | 9.66 Million HKD | 0.0% |
| 2015 FY | 9.66 Million HKD | -44.78% |
| 2015 Q3 | 9.66 Million HKD | 0.0% |
| 2015 Q2 | - HKD | 0.0% |
| 2015 Q1 | - HKD | 0.0% |
| 2014 Q3 | - HKD | 0.0% |
| 2014 FY | 17.49 Million HKD | 0.0% |
| 2014 Q1 | 17.49 Million HKD | 0.0% |
| 2013 Q4 | 17.49 Million HKD | -83.25% |
| 2013 FY | - HKD | -100.0% |
| 2013 Q1 | 129.81 Million HKD | 0.0% |
| 2013 Q2 | 104.49 Million HKD | -19.51% |
| 2013 Q3 | 104.49 Million HKD | 0.0% |
| 2012 Q1 | 87.27 Million HKD | 0.0% |
| 2012 FY | 129.81 Million HKD | 48.75% |
| 2012 Q2 | 92.58 Million HKD | 6.09% |
| 2012 Q3 | 92.58 Million HKD | 0.0% |
| 2012 Q4 | 129.81 Million HKD | 40.21% |
| 2011 Q1 | 25.31 Million HKD | 0.0% |
| 2011 Q4 | - HKD | -100.0% |
| 2011 FY | 87.27 Million HKD | 244.79% |
| 2011 Q3 | 82.32 Million HKD | 0.0% |
| 2010 Q1 | 32.07 Million HKD | 0.0% |
| 2010 Q3 | 52.11 Million HKD | 0.0% |
| 2010 FY | 25.31 Million HKD | -21.09% |
| 2009 FY | 32.07 Million HKD | 26.57% |
| 2008 FY | 25.34 Million HKD | 153.41% |
| 2007 FY | 10 Million HKD | -90.97% |
| 2006 FY | 110.78 Million HKD | 84.62% |
| 2005 FY | 60 Million HKD | 25.47% |
| 2004 FY | 47.82 Million HKD | 10.52% |
| 2003 FY | 43.27 Million HKD | -46.16% |
| 2002 FY | 80.37 Million HKD | 169.3% |
| 2001 FY | 29.84 Million HKD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 99.109% |